In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?

por Bucalau, Ana-Maria, Tancredi, Illario, Verset, Gontran
Publicado 2021

Duodenal Hemorrhage Due to an Invasive Hepatocellular Carcinoma Controlled by Transarterial Embolization

por Deforche, Maxime, Bucalau, Ana-Maria, Tancredi, Illario, Tannouri, Fadi, Verset, Gontran
Publicado 2022

Balloon-occluded chemoembolization for hepatocellular carcinoma: a prospective study of safety, feasibility and outcomes

por Bucalau, Ana-Maria, Tancredi, Illario, Pezzullo, Martina, Leveque, Raphael, Picchia, Simona, Laethem, Jean-Luc Van, Verset, Gontran
Publicado 2020

Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma

por De Wilde, Nika, Vonghia, Luisa, Francque, Sven, De Somer, Thomas, Bagdadi, Ali, Staub, Eva, Lambrechts, Jasper, Bucalau, Ana-Maria, Verset, Gontran, Van Steenkiste, Christophe
Publicado 2022

Clinical impact of (99m)Tc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patient...

por Bucalau, Ana-Maria, Collette, Benoît, Tancredi, Illario, Vouche, Michael, Pezzullo, Martina, Bouziotis, Jason, Moreno-Reyes, Rodrigo, Trotta, Nicola, Levillain, Hugo, Van Laethem, Jean Luc, Verset, Gontran
Publicado 2023